Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study.
Saved in:
| Title: | Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study. |
|---|---|
| Authors: | Juárez A; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Salas MQ; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Pedraza A; Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Suárez-Lledó M; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, 08036 Barcelona, Spain., Rodríguez-Lobato LG; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, 08036 Barcelona, Spain., Solano MT; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Serrahima A; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Nomdedeu M; Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Cid J; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, 08036 Barcelona, Spain.; Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Lozano M; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, 08036 Barcelona, Spain.; Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Charry P; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, 08036 Barcelona, Spain.; Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Arcarons J; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Llobet N; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Rosiñol L; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, 08036 Barcelona, Spain.; Institute Josep Carreras, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Fernández-Avilés F; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, 08036 Barcelona, Spain.; Institute Josep Carreras, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Rovira M; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, 08036 Barcelona, Spain.; Institute Josep Carreras, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Martínez C; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Blood Disease (ICAMS), Hospital Clínic de Barcelona, 08036 Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute-IDIBAPS, 08036 Barcelona, Spain.; Institute Josep Carreras, Hospital Clínic de Barcelona, 08036 Barcelona, Spain. |
| Source: | Cancers [Cancers (Basel)] 2024 Jul 17; Vol. 16 (14). Date of Electronic Publication: 2024 Jul 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers16142567 |
